225 related articles for article (PubMed ID: 21761146)
1. Gender-specific risk factors for incident gout: a prospective cohort study.
Chen JH; Yeh WT; Chuang SY; Wu YY; Pan WH
Clin Rheumatol; 2012 Feb; 31(2):239-45. PubMed ID: 21761146
[TBL] [Abstract][Full Text] [Related]
2. Impact of obesity and hypertriglyceridemia on gout development with or without hyperuricemia: a prospective study.
Chen JH; Pan WH; Hsu CC; Yeh WT; Chuang SY; Chen PY; Chen HC; Chang CT; Huang WL
Arthritis Care Res (Hoboken); 2013 Jan; 65(1):133-40. PubMed ID: 22933424
[TBL] [Abstract][Full Text] [Related]
3. Serum Uric Acid and the Risk of Incident and Recurrent Gout: A Systematic Review.
Shiozawa A; Szabo SM; Bolzani A; Cheung A; Choi HK
J Rheumatol; 2017 Mar; 44(3):388-396. PubMed ID: 28148699
[TBL] [Abstract][Full Text] [Related]
4. Serum urate and incidence of kidney disease among veterans with gout.
Krishnan E; Akhras KS; Sharma H; Marynchenko M; Wu E; Tawk RH; Liu J; Shi L
J Rheumatol; 2013 Jul; 40(7):1166-72. PubMed ID: 23678154
[TBL] [Abstract][Full Text] [Related]
5. Relative and attributable diabetes risk associated with hyperuricemia in US veterans with gout.
Krishnan E; Akhras KS; Sharma H; Marynchenko M; Wu EQ; Tawk R; Liu J; Shi L
QJM; 2013 Aug; 106(8):721-9. PubMed ID: 23620537
[TBL] [Abstract][Full Text] [Related]
6. Failure to reach uric acid target of <0.36 mmol/L in hyperuricaemia of gout is associated with elevated total and cardiovascular mortality.
Pérez Ruiz F; Richette P; Stack AG; Karra Gurunath R; García de Yébenes MJ; Carmona L
RMD Open; 2019; 5(2):e001015. PubMed ID: 31673414
[TBL] [Abstract][Full Text] [Related]
7. The risk of clinically diagnosed gout by serum urate levels: results from 30 years follow-up of the Malmö Preventive Project cohort in southern Sweden.
Kapetanovic MC; Nilsson P; Turesson C; Englund M; Dalbeth N; Jacobsson L
Arthritis Res Ther; 2018 Aug; 20(1):190. PubMed ID: 30157929
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Relationship Between Serum Uric Acid Levels and Cardiovascular Events in Patients With Gout: A Retrospective Analysis Using Electronic Medical Record Data.
Essex MN; Hopps M; Bienen EJ; Udall M; Mardekian J; Makinson GT
J Clin Rheumatol; 2017 Apr; 23(3):160-166. PubMed ID: 28248798
[TBL] [Abstract][Full Text] [Related]
9. The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial.
Becker MA; Schumacher HR; Espinoza LR; Wells AF; MacDonald P; Lloyd E; Lademacher C
Arthritis Res Ther; 2010; 12(2):R63. PubMed ID: 20370912
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of longitudinal changes in serum uric acid levels and associated risk of cardio-metabolic events and renal function decline in gout.
Desai RJ; Franklin JM; Spoendlin-Allen J; Solomon DH; Danaei G; Kim SC
PLoS One; 2018; 13(2):e0193622. PubMed ID: 29489919
[TBL] [Abstract][Full Text] [Related]
11. Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis.
Halpern R; Mody RR; Fuldeore MJ; Patel PA; Mikuls TR
Curr Med Res Opin; 2009 Jul; 25(7):1711-9. PubMed ID: 19485724
[TBL] [Abstract][Full Text] [Related]
12. Uric acid levels within the normal range predict increased risk of hypertension: a cohort study.
Leiba A; Vinker S; Dinour D; Holtzman EJ; Shani M
J Am Soc Hypertens; 2015 Aug; 9(8):600-9. PubMed ID: 26101171
[TBL] [Abstract][Full Text] [Related]
13. Diuretic use, increased serum urate levels, and risk of incident gout in a population-based study of adults with hypertension: the Atherosclerosis Risk in Communities cohort study.
McAdams DeMarco MA; Maynard JW; Baer AN; Gelber AC; Young JH; Alonso A; Coresh J
Arthritis Rheum; 2012 Jan; 64(1):121-9. PubMed ID: 22031222
[TBL] [Abstract][Full Text] [Related]
14. Serum uric acid, gout, and venous thromboembolism: The atherosclerosis risk in communities study.
Kubota Y; McAdams-DeMarco M; Folsom AR
Thromb Res; 2016 Aug; 144():144-8. PubMed ID: 27337701
[TBL] [Abstract][Full Text] [Related]
15. Achievement of Target Serum Uric Acid Levels and Factors Associated with Therapeutic Failure among Japanese Men Treated for Hyperuricemia/Gout.
Katayama A; Yokokawa H; Fukuda H; Ono Y; Isonuma H; Hisaoka T; Naito T
Intern Med; 2019 May; 58(9):1225-1231. PubMed ID: 30626825
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of gout in women: Fifty-two-year followup of a prospective cohort.
Bhole V; de Vera M; Rahman MM; Krishnan E; Choi H
Arthritis Rheum; 2010 Apr; 62(4):1069-76. PubMed ID: 20131266
[TBL] [Abstract][Full Text] [Related]
17. [Characteristics and clinical significance of body composition in gout patients].
Deng C; Li QH; Yang LJ; Liang JJ; Mo YQ; Lin JZ; Zheng DH; Dai L
Zhonghua Nei Ke Za Zhi; 2019 Oct; 58(10):751-757. PubMed ID: 31594173
[No Abstract] [Full Text] [Related]
18. Colchicine Significantly Reduces Incident Cancer in Gout Male Patients: A 12-Year Cohort Study.
Kuo MC; Chang SJ; Hsieh MC
Medicine (Baltimore); 2015 Dec; 94(50):e1570. PubMed ID: 26683907
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of serum uric acid levels and incident metabolic syndrome in a Korean rural cohort.
Yadav D; Lee ES; Kim HM; Choi E; Lee EY; Lim JS; Ahn SV; Koh SB; Chung CH
Atherosclerosis; 2015 Jul; 241(1):271-7. PubMed ID: 25957887
[TBL] [Abstract][Full Text] [Related]
20. Attenuating the mortality risk of high serum uric acid: the role of physical activity underused.
Chen JH; Wen CP; Wu SB; Lan JL; Tsai MK; Tai YP; Lee JH; Hsu CC; Tsao CK; Wai JP; Chiang PH; Pan WH; Hsiung CA
Ann Rheum Dis; 2015 Nov; 74(11):2034-42. PubMed ID: 25053714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
